SCHEMBL22773372

SCHEMBL22773372

Cn1cc(C(=C2CCNCC2)c2ccccc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 12/20 0.49
▸ OPRM1 P35372 9/20 0.49
▸ OPRK1 P41145 3/20 0.49
▸ SETD7 Q8WTS6 1/20 0.49
▸ KCNH2 Q12809 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HRH1 P35367 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ HTR3A P46098 1/20 0.41
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ABCB11 O95342 1/20 0.38
▸ FNTA P49354 1/20 0.36
▸ FNTB P49356 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2457390 0.80 OPRD1 (0.61) OPRD1OPRM1OPRK1SETD7KCNH2
SCHEMBL22773257 0.79 SETD7 (0.53) OPRD1OPRM1OPRK1SETD7KCNH2
Bromide SCHEMBL10598951 0.79 OPRD1 (0.59) OPRD1OPRM1OPRK1SETD7KCNH2
Hydrochloric Acid SCHEMBL7647391 0.79 OPRD1 (0.59) OPRD1OPRM1OPRK1SETD7KCNH2
SCHEMBL14252952 0.78 SETD7 (0.51) OPRD1OPRM1OPRK1SETD7KCNH2
SCHEMBL12752301 0.77 SETD7 (0.50) OPRD1OPRM1OPRK1SETD7KCNH2
SCHEMBL8316576 0.74 OPRD1 (0.60) OPRD1OPRM1OPRK1SETD7KCNH2
SCHEMBL9434960 0.73 OPRD1 (0.57) OPRD1OPRM1OPRK1SETD7KCNH2
SCHEMBL1472918 0.72 GPR119 (0.48) SETD7FNTAFNTB
SCHEMBL29479614 0.71 OPRD1 (0.44) OPRD1OPRM1OPRK1SETD7KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11420961-B2 Heterocyclic compounds HOFFMANN-LA ROCHE INC. (US) 2022-08-23 — — US disclosed
EP-3717477-B1 NEW HETEROCYCLIC COMPOUNDS HOFFMANN LA ROCHE (CH) 2022-07-20 — — EP disclosed
US-20200392125-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2020-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11420961-B2 Heterocyclic compounds LPXN, MLX, CCNY OPRD1 1395/4885OPRM1 549/4885OPRK1 1592/4885
US-20200392125-A1 HETEROCYCLIC COMPOUNDS LPXN, MLX, CCNY OPRD1 1395/4885OPRM1 549/4885OPRK1 1592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback